December 10, 2019 at 1:14 pm

FDA’s Fast-Tracked Drugs May Pose Increased Risks

A new study finds pharmaceutical products rushed through an expedited FDA approved process are “48% more likely to get either a black-box warning or to receive contraindications that restrict the drug’s use.”
Read the full story here.
December 6, 2019 at 1:56 pm

Inappropriate Medication Use and Polypharmacy Increases Hospitalization

“Older adults prescribed more medications are likely to be hospitalized for an adverse drug reaction. Moreover, adverse drug events account for more morbidity and mortality than most chronic diseases, with death rates higher than many common cancers,” state authors Dee Mangin of McMaster University and Doron Garfinkel of Israel Cancer Association.
Their research addresses the widespread effects of inappropriate medication use and polypharmacy (IMUP).
Get the full story here.
December 5, 2019 at 1:36 pm

99% of Serious Adverse Drug Effects Are Never Reported

“After examining side effects that were conveyed to the regulator for five widely used medicines — two different types of arthritis treatments, an antipsychotic, and a blood thinner — just 1% of an estimated 276,000 serious adverse events had been reported in 2017.”
Get the full story here.
December 4, 2019 at 9:56 am

Suicide Loss & Grief Support Group Open to All

MISSD, JCFS Chicago and No Shame on U are partnering to provide suicide loss and community grief support made possible by JUF’s Breakthrough Fund. If you’re in the Chicago area, please know all are welcome to join our drop-in support group.
Meeting dates are: January 23, February 27 and March 26 from 7 to 8:30 pm and held at 5150 Golf Rd., SkokieIL. Click here for more info.
November 27, 2019 at 11:44 am

Over-the-Counter Meds Can Impact Airline Safety

FAA releases new medication list designed to help passengers and pilots be safer given that “some drugs may compromise a pilot’s ability to control the aircraft and/or adversely affect judgment and decision making.”
Get the full story here.
November 25, 2019 at 2:13 pm

New VA Tool May Reduce Polypharmacy

Veterans may benefit from a new tool designed by the VA to reduce polypharmacy and related adverse drug effects. Polypharmacy can lead to dangerous drug interactions and currently “no standardized approach exists to holistically examine a patient’s complete medication profile, identify potentially inappropriate medications and determine which medications are compatible, safe, necessary and indicated.”
Read the full article here.
November 21, 2019 at 12:34 pm

MISSD Interview on K-9s for Veterans

“When I was in the army I wanted to try to quit smoking,” says veteran who was given a smoking-cessation drug. “I started feeling very angry & aggressive. I immediately called up my doctor & said look I don’t want to take this anymore…”
Another eye-opening interview with MISSD founder, Wendy Dolin, on the K-9’s for Veterans’ talk show. MISSD is honored to work with veterans to increase awareness of adverse drug effects and save lives.
Listen to last week’s interview here.
November 20, 2019 at 1:12 pm

Guest Post from One of Many

Every week, MISSD receives letters and emails similar to this one from Kim. As the public becomes increasingly aware of adverse drug effects such as akathisia, we hope fewer people will have adverse experiences to share.
Today we publish Kim’s letter as it was received because sharing firsthand knowledge of akathisia symptoms can help patients and doctors better identify and respond to akathisia.

My name is Kim and I am a 46 year old police officer from Toronto. In 2001, I gave birth to my first child and immediately experienced post partum depression. I recognized it right away and spoke up. I was prescribed Paxil.  After two days I felt extremely hopeless, restless and agitated. My thoughts were that I wanted to find a train to lay in front of to die. I called my husband at work who came home immediately and took me to the hospital. My baby was 5 days old. I was admitted into the psych ward where I voiced my opinion that I believed it was the new medication. The psychiatrist dismissed it saying “impossible” but I refused to take it when they gave it to me. So he switched me to Effexor.  He said he believed I was simply a burnt out new mom who has had no sleep. I left the hospital after 5 days and remained on Effexor successfully for 2 years before coming off.

Oddly enough I had this experience once again in  2005. I get debilitating migraines and I had an extremely bad one where my husband took me to emerge. The on-call doctor gave me a “migraine cocktail” via IV, which included Maxeran and Toradol.  After about a half hour I was very fidgety and agitated. My husband said I was unable to sit still on the hospital bed. I wanted to leave the hospital, once again to find a train track to lay down on. I fought the feeling and told my family doctor a few weeks later at an appointment. He said it’s a very rare and dangerous side effect of Maxeran that causes “psychosis”.

In 2008 I had my second child with no episodes of post partum depression.

These are the only two times in my life I’ve experienced such extreme suicidal ideations, but it’s enough for me to never want to try these medications again. My children are now 11 and 18 years old and my supportive husband is still by my side. I am forever grateful for my family, and the fact that I overcame those feelings so I’m here today to enjoy them.

It wasn’t until I just read the extremely sad story of Stewart Dolin, that I realized that I should have notified the drug company after these incidents.

My sincere condolences go out to his family.

November 19, 2019 at 2:52 pm

Antidepressant Withdrawal in the News

It’s good to see a leading women’s magazine cover withdrawal problems associated with drugs commonly marketed as antidepressants. We hope future articles will cover akathisia given antidepressant withdrawal can cause akathisia.
Read the article here.
November 15, 2019 at 3:11 pm

Medical PR & Truth

Dr. Christopher Lane spotlights medical ethics, or lack there of, in his informative Psychology Today article. Documents cited in litigation “show comprehensive evidence of ghostwriting that “manipulated outcome data,” named authors with financial ties to the drug maker sponsoring the article, but with “little or no direct involvement” in the study to which they lent their names, and publication in the flagship American Journal of Psychiatry being “facilitated by the journal editor who also had financial ties to” the sponsoring pharmaceutical company.
Get the full story here.